Northern Trust Corp Grows Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Northern Trust Corp boosted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 18.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,247,532 shares of the company's stock after acquiring an additional 193,202 shares during the period. Northern Trust Corp owned 1.03% of Revvity worth $139,237,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of RVTY. T. Rowe Price Investment Management Inc. grew its position in shares of Revvity by 16.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock valued at $2,317,170,000 after purchasing an additional 2,969,326 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Revvity by 17.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock valued at $851,764,000 after purchasing an additional 1,151,821 shares in the last quarter. Norges Bank acquired a new stake in Revvity in the fourth quarter valued at about $127,801,000. Invesco Ltd. lifted its holdings in shares of Revvity by 18.8% in the fourth quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock worth $194,306,000 after acquiring an additional 274,923 shares during the last quarter. Finally, Proficio Capital Partners LLC grew its holdings in shares of Revvity by 12,298.3% during the 4th quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock valued at $21,850,000 after purchasing an additional 194,190 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Raymond James reiterated an "outperform" rating and issued a $120.00 price target (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Barclays lowered their price target on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Sanford C. Bernstein cut Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. Robert W. Baird decreased their target price on Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Finally, The Goldman Sachs Group decreased their price objective on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Trading Up 2.7 %

Shares of RVTY traded up $2.49 during midday trading on Thursday, hitting $94.08. The stock had a trading volume of 240,013 shares, compared to its average volume of 928,959. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm has a market cap of $11.30 billion, a PE ratio of 42.55, a price-to-earnings-growth ratio of 3.82 and a beta of 1.02. Revvity, Inc. has a 1 year low of $88.53 and a 1 year high of $129.50. The stock's 50 day moving average is $101.54 and its 200 day moving average is $111.55.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The company had revenue of $664.76 million during the quarter, compared to analyst estimates of $662.30 million. During the same quarter last year, the business posted $0.98 EPS. The firm's revenue for the quarter was up 2.3% on a year-over-year basis. As a group, analysts forecast that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity's dividend payout ratio (DPR) is 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.